Back to mobile site

More on AMLX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-2.7% Growth)
- Ratings (8.3 Score)
- Holders

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Amylyx Pharmaceuticals (NQ:AMLX)
Delayed: 29.26 +0.23 (0.79%)
Prev. Close $29.03  
Open$28.84 
52 Wk High$ 
52 Wk Low$ 
Day High$30.00 
Day Low$28.51 
P/E N/A  
EPS$ 
Volume687,930 

Friends, Peers and Foes (?): HUM, FIVE, BAX, HTZ, TMCI (more...)

Oct 18, 2026 08:00 PM U.S. biotech SMids: Q3 earnings preview
Oct 7, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Oct 05 Filed by: MILNE GEORGE M JR
Oct 6, 2026 08:01 AM Amylyx to present Phase 3 avexitide trial data at ObesityWeek 2026
Oct 6, 2026 08:00 AM Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
Oct 5, 2026 04:38 PM Form 144 Amylyx Pharmaceuticals, Filed by: MILNE GEORGE M JR
Oct 1, 2026 07:24 AM Amylyx Pharmaceuticals (AMLX) Reiterated at Buy by Stifel on Ph3 Data for Avexitide
Sep 23, 2026 09:00 AM Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Bedrosian Camille L
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: FRATES JAMES M
Sep 14, 2026 04:00 PM Form 4 Amylyx Pharmaceuticals, For: Sep 10 Filed by: Klee Justin B.
View All Articles

Entities mentioned with AMLX

View All Entities